© 2022 MJH Life Sciences and Contemporary OB/GYN. All rights reserved.
© 2022 MJH Life Sciences™ and Contemporary OB/GYN. All rights reserved.
December 22, 2021
Compared with tamoxifen, aromatase inhibitors were revealed to be more effective in reducing the rate of recurrence in ER+ breast cancer among premenopausal women receiving ovarian suppression.